A Mass Spectrometry Assay to Simultaneously Analyze ROS1 and RET Fusion Gene Expression in Non–Small-Cell Lung Cancer
- 1 February 2015
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 10 (2) , 381-386
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Comparison of IHC, FISH and RT-PCR Methods for Detection of ALK Rearrangements in 312 Non-Small Cell Lung Cancer Patients in TaiwanPLOS ONE, 2013
- The transcriptional landscape and mutational profile of lung adenocarcinomaGenome Research, 2012
- Analysis of Receptor Tyrosine Kinase ROS1-Positive Tumors in Non–Small Cell Lung Cancer: Identification of a FIG-ROS1 FusionClinical Cancer Research, 2012
- A Novel Mass Spectrometry–Based Assay for Diagnosis of EML4-ALK–Positive Non–Small Cell Lung CancerJournal of Thoracic Oncology, 2012
- ROS1 Rearrangements Define a Unique Molecular Class of Lung CancersJournal of Clinical Oncology, 2012
- KIF5B-RET fusions in lung adenocarcinomaNature Medicine, 2012
- A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencingGenome Research, 2011
- High-throughput detection of fusion genes in cancer using the Sequenom MassARRAY platformLaboratory Investigation, 2011
- Somatic mutations affect key pathways in lung adenocarcinomaNature, 2008
- Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung CancerCell, 2007